Eric Lefkofsky’s Recent Healthcare Developments

Eric Lefkofsky is a Chicago based entrepreneur who together with others co-founded Tempus Labs. This is an institution that applies data analytics to provide solutions for cancer patients that will enable them to lead normal lives. The institution was created in 2015, and it has rapidly developed into one of the most reputable tech health startup bodies in the country. This development has been to a great extent due to the influence of Eric Lefkofsky. Eric and his wife Liz are philanthropists who have in the past given to numerous charity bodies. They have a group called Lefkofsky Family Foundation that has been active since its inception.

Tempus Labs is highly committed towards developing cancer remedies to people. The institution has formed mergers with numerous National Cancer Institutes in the country to ensure that they reach out to many patients as possible.
They offer a wide range of services that include the following:

Conducting of tests to diagnose the presence of cancer Characterization of tumors in a bid to give specific treatment solutions to the patients

Machine learning and use of patient data to create an effective treatment program. The efforts of Tempus Labs towards bringing relief to cancer patients have not gone unnoticed. Recently, the research institution was featured in the yearly Eric Topol’s listing that rates companies that merges healthcare with technology. Tempus Labs have been recommended for its efforts towards bringing changes to the health industry that are projected to revolutionize the entire sector in the near future.

Tempus has been highly rated due to its application of gene therapy and gene editing in the treatment of ailments that had no cure in the past. Through gene therapy, it is now possible to treat inherited loss of sight that was impossible to curb in the past and eventually led to blindness. Tests are still ongoing on the application of gene editing to treat Hunter syndrome, and the progress is positive.

Tempus Labs in collaboration with Stanford University have also been working on a formula to simplify skin cancer diagnosis. They have numerous other FDA approved developments that include glucose sensors that are used for direct injection of insulin to patients. Also on the list of their numerous works is an algorithm that can detect heart attacks and gives a signal before the problem escalates to uncontrollable levels.

About Eric Lefkofsky: www.lightbank.com/team/eric-lefkofsky

New Immunotherapies Could Be Cost Effective Says Dr. David Samadi

Using micrograms of two medicines, injected into mice, scientists saw cancerous tumors disappear. Lenox Hill Hospital head of Urology, Dr. David Samadi has written about this technique in a previous article, “Re-programming Your Body To Fight Cancer.” 90 mice were tested, and Standford University researchers say human clinical trials should begin by end of year.

This could be a quick and relatively inexpensive strategy, less expensive and with fewer side effects than other immunotherapies available today. The strategy developed aims to reactivate the ability of the immune system to recognize and destroy cancer cells. Dr. Samadi says this will be a pioneer in the field of immunotherapy.

The two medicines have two different functions: one is an amplifier of a particular receptor (OX40), which is present on the T cells of the immune system, while the second one binds to this receptor and guides against cancer.The mix worked well in laboratory mice with lymphoma that had the tumor transplanted into two distinct parts of the body. 87 out of 90 mice were healed from cancer. The researchers observed similar results in mice with breast, colon and cutaneous melanoma tumors.

According to Dr. David Samadi, these new immunotherapies are encouraging. This particular approach ignores the need to identify the tumor’s specific immune targets and does not require the general activation of the whole immune system. Hopefully, in the future, there won’t be a limit on the types of cancers that are treatable using this approach, added Dr. Samadi.

What Is Immunotherapy?

It’s a relatively new effective weapon to fight cancer and lengthen the long-term survival of patients. This technique aims at restoring the immune system using antibodies that “reactivate traffic lights” blocked by the tumor, so that the body can again attack the diseased cells. Continuation of clinical trials may result in a relatively inexpensive strategy at beating cancer says Dr. Samadi.

Dr. David Samadi specializes in urologic diseases, and is internationally known for his Samadi Modified Advanced Robotic Technique (SMART surgery). Dr. Samadii customized a prostate surgery procedure, resulting in a less invasive technique that cut down the surgery time, as well as the patient’s recovery time. This particular surgery protects the surrounding nerve bundles and Dr. Samadi has performed over 7,000 surgeries, domestically and internationally.

Dr. Samadi holds multiple “America’s Top Doctor” and “America’s Top Doctor for Cancer” awards, and was named “Best Doctor” for five consecutive years, and “Most Compassionate Doctor” from 2010 to 2013. In addition to his work at Lenox Hill Hospital, he is a medical correspondent for Fox News, and has his own show, Sunday Housecall, that airs on Sundays at 12:30pm.

For details: prostatecancer911.com/david-samadi/

The Cancer Treatment Centers of America: A Brilliant Place For Career Development

Cancer is a disorder that affects millions of people all over the world, which is why the need to offer good cancer care is imminent. The Cancer Treatment Centers of America is one institution that aims to provide top-tier cancer treatment to patients that are specific to the condition that they have and other kinds of factors.Often, when people are diagnosed with something like cancer, hospitals and doctors tend to offer them only one course of treatment. For patients, there is no one size fits all policy, and different kinds of cancers need different directions of treatment. At Cancer Treatment Centers of America, every patient that comes here is evaluated and offered a treatment that is unique to them and the kind of cancer that they are diagnosed with.

Treating cancer isn’t only about attacking the tumor and removing it from the body. The disorder is filled with physical and emotional challenges that need to be dealt with, along with the financial concerns that patients might have. The Cancer Treatment Centers of America works in a way where patients are assisted all through so that they can have a smoother course of treatment.One of the things that set the Cancer Treatment Centers of America apart from other hospitals in the country is the staff that they have on board. The organization has a large pool of doctors and professionals who are dedicated to offering an incredibly high quality of services to the patients who come to them. The Cancer Treatment Centers of America takes great care in ensuring that every one of the professionals working with them in on board with the kind of services that they provide, and meets the quality standards that the organization has laid out. With some of the most brilliant doctors in the country working at the centers, patients can expect an excellent quality of treatment every time they visit the Cancer Treatment Centers of America.

The organization operates through several centers throughout the country. The organization’s centers are located in Atlanta, Chicago, Tulsa, Phoenix, Scottsdale and many more. Because of how many centers the organization has under its name, there are always opportunities available for those who are looking to enter into the medical field. From the medical staff of doctors and nurses to the administrative staff, several positions are available in the organization. The Cancer Treatment Centers of America’s outlets have consistently gained a reputation for being an excellent place to work and a place that helps professionals develop their skills and professional abilities. For those who are looking for a workplace that enables them to grow and have a fulfilling career at the same time, the Cancer Treatment Centers of America is the place to be.

How Clay Siegall has revolutionized Cancer Research

Clay Siegall is a U.S based biotechnology experts who has gained global respect due to his positive contributions to the improvement of cancer treatments. He is also skilled in genetics and has been using his expertise in developing gene-based therapies. Siegall kicked off his career about three decades ago and had served different institutions in the private and public sectors. He currently acts as the CEO of Seattle Genetics, which is a biotechnology research organization that he co-founded in 1998. The firm has been working towards the development of effective cancer therapies that do not cause health problems to the patients. Chemotherapies are known to have side effects such as loss of hair and infertility.

Seattle Genetics is currently a thriving research hub that comprises of a couple of the biotechnology experts who are committed to developing the best cancer treatments. The FDA has approved some targeted cancer therapies that have been created by the company. Seattle Genetics is greatly appreciated for being the founder of the antibody drug conjugates technology that various pharmaceutical corporations use in making cancer drugs. The firm generated revenue from the technology by licensing manufacturers to use its technology, selling ADC-based drugs, and working with various companies to produce drugs externally. Seattle Genetics has partnered with Bayer, Genentech, and Takeda Pharmaceuticals.

Siegall is an excellent administrator, and he has displayed this for the past two decades that he has been the head of Seattle Genetics. He led the firm in having a successful IPO in 2001. Clay has also ensured that the company gets sufficient funding from private and public sources. Under his leadership, the Seattle Technologies researchers have developed customized cancer therapies that have penetrated the local and international markets.

The experience that Clay Siegall has gained the past three decades that he has been a biotechnology researcher has made him be considered as an intelligent scientist. Companies such as Biopharmaceuticals, Mirna, and Ultragenyx Therapeutics have appointed him to serve as a member of their boards. During his time at Seattle Genetics, he has successfully developed several drugs and has 15 patents. Under his management, the company made sells that added up to more than $418 million in 2016. The value of its shares had grown to $66 per share by mid-May. Seattle Genetics has raised a lot of money from the commercialization of a drug that is called Adcetris. The cost of using the drug per annum is between $230,000 and $330,000.